Stage 4 Cancer Patient Now Disease-Free After Groundbreaking Liver Transplant

A Silent Disease Strikes Without Warning

Amy Piccioli was just 39 when she rushed to an emergency room in Los Angeles, thinking she was simply dehydrated from a stomach bug. A CT scan revealed a mass in her colon and multiple lesions in her liver, which led to a colorectal cancer diagnosis — despite having "zero signs." The busy CPA and mother of three had "zero signs of colorectal cancer. No pain, no changes in bowel habits and no family history," making her diagnosis in May 2024 all the more shocking.

"Because the cancer had already spread, it was automatically a stage 4 diagnosis." For Piccioli, the news was devastating. "I just went numb — I couldn't believe it. Immediately, you have those feelings of panic and fear." Her case highlights a troubling trend: rates in people younger than age 50 have increased by about 2% each year , and colorectal cancer has become the leading cause of cancer-related deaths in people under 50.

Finding Hope in an Unlikely Solution

After multiple rounds of chemotherapy and immunotherapy showed promise by shrinking her tumors, Piccioli faced a harsh reality. "The cancer was all over my liver. In cases where the cancer is confined to one side of the liver, they can basically cut that portion out … but in my case, a resection was not a possibility because the cancer was everywhere." Traditional treatment offered little hope for long-term survival.

That's when her medical team suggested something extraordinary: a liver transplant specifically for cancer patients. Northwestern Medicine is among a small number of health systems in the United States pioneering transplantation for select patients with metastatic cancers of the colon or lung. The program represents a dramatic shift in cancer treatment, offering "10% five‑year survival" with chemotherapy alone versus "60% to 80%" five-year survival rates for carefully selected transplant patients, with "some patients achieve long‑term cure."

A Friend's Life-Changing Gift

When Piccioli shared the living-donor screening information with her network, an unexpected match emerged. Lauren Prior, the daughter of longtime family friends who live in Chicago and have known Piccioli since she was a toddler , stepped forward as a perfect donor. "It felt like fate. Lauren and her family had already told us we could stay with them in Chicago while I recover from the surgery. And then she turned out to be my perfect match."

In December 2025, Piccioli received a portion of her close family friend Lauren Prior's liver, and three months later, doctors confirmed Piccioli has 'no evidence of disease'. The transplant made her the first person at Northwestern to receive a living donor transplantation for metastatic colon cancer. Her recovery has been remarkable: "The first week or two were difficult, but by week four, I was up and around, getting back to doing normal life things. About two months out, I started working out again. I'm now three months out and feel completely normal."

Expanding Treatment Horizons

Piccioli's success story represents more than individual triumph—it signals a potential paradigm shift in cancer care. "Because transplant for colorectal liver metastases is still so new and offered at only a handful of centers, it's not yet on the radar for every clinician and patient," explains Dr. Satish Nadig, director of Northwestern's transplant center. Her case demonstrates that patients previously considered terminal may have life-saving options they never knew existed.

Now cancer-free and advocating for awareness during Colorectal Cancer Awareness Month, Piccioli has a clear message: "If your cancer has spread to your liver, ask your doctor about a transplant. It might be an option you didn't know existed. That information could save someone's life." Her journey from a routine ER visit to groundbreaking treatment underscores how rapidly cancer medicine is evolving, offering new hope where none existed before.